Intertek Opened a New Storage Unit in Royston
Published By : 20 May 2015 | Published By : QYRESEARCH
A new storage unit for the pharmaceutical market that has been opened this week will fuel the life-sciences market in Cambridge. Intertek opened this 8,000 sq. ft. large unit at Royston on Tuesday 19, 2015. It will permit the clients of the firm to set up the recommended and personalized storage conditions with a modern environmental monitoring system. The unit has a storage capacity totaling to 190,000 liters.
Mr. Mark Hammond, the laboratory director of the firm, stated that the new site is designed to complement the work of Intertek of developing products for the pharmaceuticals, customers’ healthcare, and the biologics industries. This new unit, integrated with their experience and the knowledge of pharmaceutical testing, will bring in a range of storage solutions with the options for client personalized conditions and the risk management storage to meet the raised demands from their global clients, he stated.
Ms. Harriet Fear, the CEO of the life sciences membership organization named One Nucleus based in Cambridge, has also hailed the development. She stated that the research and development is the heart of the global pharmaceutical market, which invests more than any other industrial market in the UK, with up to approx US$17.87 million spent every day. It is good to see that Intertek is favoring clients across the globe in their research and development by investing in this remarkable stability storage unit in the heart of the largest life science and healthcare region in Europe.
The firm has offices in Melbourne, as well as a runs network of more than 1,000 laboratories that employ 38,000 people from all over the world. The chief executive of the firm Mr. Martin van Dorp stated that Intertek has more than 20 years of experience in the analytical testing and formulation for the products to be inhaled for the treatments for asthma, diabetes, cystic fibrosis, and chronic obstructive pulmonary disease.